VYGR
Voyager Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VYGR Filings
Filing Date
Form Description
Form Type
2025-12-02
Form EFFECT - Notice of Effectiveness
2025-12-02 ·
Form EFFECT - Notice of Effectiveness
2025-12-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-10
Form S-3 - Registration statement under Securities Act of 1933
2025-11-10 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-11-10
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-10 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
2025-10-07
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-07 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-03
Form 144 - Report of proposed sale of securities
Ownership
2025-10-03 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-03
Form 144 - Report of proposed sale of securities
Ownership
2025-10-03 · Ownership
Form 144 - Report of proposed sale of securities
